These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

139 related articles for article (PubMed ID: 19493020)

  • 1. Age-dependent increase of FVIII:C in mild haemophilia A.
    Miesbach W; Alesci S; Krekeler S; Seifried E
    Haemophilia; 2009 Sep; 15(5):1022-6. PubMed ID: 19493020
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A 6-year follow-up of dosing, coagulation factor levels and bleedings in relation to joint status in the prophylactic treatment of haemophilia.
    Ahnström J; Berntorp E; Lindvall K; Björkman S
    Haemophilia; 2004 Nov; 10(6):689-97. PubMed ID: 15569163
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Risk of inhibitor development in mild haemophilia A increases with age.
    Mauser-Bunschoten EP; Den Uijl IE; Schutgens RE; Roosendaal G; Fischer K
    Haemophilia; 2012 Mar; 18(2):263-7. PubMed ID: 21851507
    [TBL] [Abstract][Full Text] [Related]  

  • 4. DDAVP responsiveness in children with mild or moderate haemophilia A correlates with age, endogenous FVIII:C level and with haemophilic genotype.
    Seary ME; Feldman D; Carcao MD
    Haemophilia; 2012 Jan; 18(1):50-5. PubMed ID: 21592259
    [TBL] [Abstract][Full Text] [Related]  

  • 5. In vivo recovery of factor VIII and factor IX: intra- and interindividual variance in a clinical setting.
    Björkman S; Folkesson A; Berntorp E
    Haemophilia; 2007 Jan; 13(1):2-8. PubMed ID: 17212717
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Retrospective analysis of differences in annual factor VIII utilization among haemophilia A patients.
    Epstein J; Xiong Y; Woo P; Li-McLeod J; Spotts G
    Haemophilia; 2012 Mar; 18(2):187-92. PubMed ID: 21883704
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effects of primary and secondary prophylaxis on the clinical expression of joint damage in children with severe haemophilia A. Results of a multicenter non-concurrent cohort study.
    Schobess R; Kurnik K; Friedrichs F; Halimeh S; Krümpel A; Bidlingmaier C; Nowak-Göttl U
    Thromb Haemost; 2008 Jan; 99(1):71-6. PubMed ID: 18217137
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prospective surveillance study of haemophilia A patients switching from moroctocog alfa or other factor VIII products to moroctocog alfa albumin-free cell culture (AF-CC) in usual care settings.
    Parra Lopez R; Nemes L; Jimenez-Yuste V; Rusen L; Cid AR; Charnigo RJ; Baumann JA; Smith L; Korth-Bradley JM; Rendo P
    Thromb Haemost; 2015 Oct; 114(4):676-84. PubMed ID: 26293201
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Association between phenotype and genotype in carriers of haemophilia A.
    Miesbach W; Alesci S; Geisen C; Oldenburg J
    Haemophilia; 2011 Mar; 17(2):246-51. PubMed ID: 21118332
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Treatment of haemophilia in the elderly.
    Miesbach W; Krekeler S; Alesci S
    Hamostaseologie; 2009 Oct; 29 Suppl 1():S29-31. PubMed ID: 19763355
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Does FVIII-activity increase with age in patients with haemophilia A and carriers of haemophilia A?].
    Delbrück C; Haferland I; Scholz K; Asmelash G; Makki V; Müller S; Krekeler S; Alesci S; Miesbach W
    Hamostaseologie; 2011 Nov; 31 Suppl 1():S24-8. PubMed ID: 22057150
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Use of pharmacokinetics in the coagulation factor treatment of patients with haemophilia.
    Shapiro AD; Korth-Bradley J; Poon MC
    Haemophilia; 2005 Nov; 11(6):571-82. PubMed ID: 16236106
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comparing prophylaxis with episodic treatment in haemophilia A: implications for clinical practice.
    Manco-Johnson M
    Haemophilia; 2007 Sep; 13 Suppl 2():4-9. PubMed ID: 17685917
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pharmacokinetics and dose requirements of factor VIII over the age range 3-74 years: a population analysis based on 50 patients with long-term prophylactic treatment for haemophilia A.
    Björkman S; Folkesson A; Jönsson S
    Eur J Clin Pharmacol; 2009 Oct; 65(10):989-98. PubMed ID: 19557401
    [TBL] [Abstract][Full Text] [Related]  

  • 15. One-stage and chromogenic FVIII:C assay discrepancy in mild haemophilia A and the relationship with the mutation and bleeding phenotype.
    Cid AR; Calabuig M; Cortina V; Casaña P; Haya S; Moret A; Cabrera N; Aznar JA
    Haemophilia; 2008 Sep; 14(5):1049-54. PubMed ID: 18540892
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Perioperative treatment of hemophilia A patients: blood group O patients are at risk of bleeding complications.
    Hazendonk HC; Lock J; Mathôt RA; Meijer K; Peters M; Laros-van Gorkom BA; van der Meer FJ; Driessens MH; Leebeek FW; Fijnvandraat K; Cnossen MH
    J Thromb Haemost; 2016 Mar; 14(3):468-78. PubMed ID: 26714028
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Assay discrepancy in mild haemophilia A: entire population study in a National Haemophilia Centre.
    Poulsen AL; Pedersen LH; Hvas AM; Poulsen LH; Thykjaer H; Ingerslev J
    Haemophilia; 2009 Jan; 15(1):285-9. PubMed ID: 19149854
    [TBL] [Abstract][Full Text] [Related]  

  • 18. DDAVP infusion in haemophilia A carriers: different behaviour of plasma factor VIII and von Willebrand factor.
    Casonato A; Dannhauser D; Pontara E; Bertomoro A; Orazi B; Santarossa L; Zerbinati P; Girolami A
    Blood Coagul Fibrinolysis; 1996 Jul; 7(5):549-53. PubMed ID: 8874865
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Continuous infusion of factor concentrates in children with haemophilia A in comparison with bolus injections.
    Bidlingmaier C; Deml MM; Kurnik K
    Haemophilia; 2006 May; 12(3):212-7. PubMed ID: 16643203
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Measurement of global haemostasis in severe haemophilia A following factor VIII infusion.
    Lewis SJ; Stephens E; Florou G; Macartney NJ; Hathaway LS; Knipping J; Collins PW
    Br J Haematol; 2007 Sep; 138(6):775-82. PubMed ID: 17672884
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.